Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Cancer
Related studies linked through entity extraction aliases.
Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients
- Status
- TERMINATED
- Phase
- PHASE2
Study of XL820 Given Orally Daily to Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)
- Status
- COMPLETED
- Phase
- PHASE2
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
- Status
- COMPLETED
- Phase
- N/A
Characterization of the Pharmacokinetics of Oral Selenium Compounds in Humans Before and Following Supplementation
- Status
- COMPLETED
- Phase
- N/A
Role of Gene Variation in Effectiveness of Gleevec Treatment
- Status
- COMPLETED
- Phase
- N/A
Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance)
- Status
- COMPLETED
- Phase
- N/A
Physicians Survey on Genetic Testing
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy.
- Status
- COMPLETED
- Phase
- PHASE3
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
- Status
- COMPLETED
- Phase
- N/A
A Prospective Study of Diet and Cancer in Members of the American Association of Retired Persons
- Status
- COMPLETED
- Phase
- N/A
Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks
- Status
- COMPLETED
- Phase
- PHASE2
An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four Weeks
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of IL-21 to Treat Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of XL647 Administered Orally Daily to Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
US-Doppler and Procoagulant Microparticles for the Diagnosis of Asymptomatic DVT in Advanced Cancer Patients With Poor Performance Status
- Status
- COMPLETED
- Phase
- N/A
Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1